- Home
- GPOR vs BDTX Comparison
GPOR vs BDTX Comparison
Compare GPOR & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPOR
- BDTX
- Stock Information
- Founded
- GPOR 1997
- BDTX 2014
- Country
- GPOR United States
- BDTX United States
- Employees
- GPOR N/A
- BDTX N/A
- Industry
- GPOR Oil & Gas Production
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GPOR Energy
- BDTX Health Care
- Exchange
- GPOR Nasdaq
- BDTX Nasdaq
- Market Cap
- GPOR 3.2B
- BDTX 181.4M
- IPO Year
- GPOR N/A
- BDTX 2020
- Fundamental
- Price
- GPOR $177.67
- BDTX $4.01
- Analyst Decision
- GPOR Buy
- BDTX Strong Buy
- Analyst Count
- GPOR 9
- BDTX 5
- Target Price
- GPOR $212.00
- BDTX $10.40
- AVG Volume (30 Days)
- GPOR 248.7K
- BDTX 1.1M
- Earning Date
- GPOR 11-04-2025
- BDTX 11-04-2025
- Dividend Yield
- GPOR N/A
- BDTX N/A
- EPS Growth
- GPOR N/A
- BDTX N/A
- EPS
- GPOR N/A
- BDTX 0.25
- Revenue
- GPOR $1,135,446,000.00
- BDTX $70,000,000.00
- Revenue This Year
- GPOR $57.61
- BDTX N/A
- Revenue Next Year
- GPOR $11.37
- BDTX N/A
- P/E Ratio
- GPOR N/A
- BDTX $16.04
- Revenue Growth
- GPOR 26.64
- BDTX N/A
- 52 Week Low
- GPOR $136.45
- BDTX $1.20
- 52 Week High
- GPOR $210.32
- BDTX $4.45
- Technical
- Relative Strength Index (RSI)
- GPOR 48.33
- BDTX 59.47
- Support Level
- GPOR $173.98
- BDTX $3.69
- Resistance Level
- GPOR $184.93
- BDTX $4.45
- Average True Range (ATR)
- GPOR 6.34
- BDTX 0.26
- MACD
- GPOR -1.08
- BDTX -0.00
- Stochastic Oscillator
- GPOR 21.53
- BDTX 50.30
About GPOR Gulfport Energy Corporation
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets predominantly located in the Appalachia and Anadarko basins in the United States. Its principal properties are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.